Adverse drug reactions in hospitalized psychiatric patients

Annals of Pharmacotherapy

Volumn 44, Issue 5, 2010, Pages 819-825

  Thomas, Michele ^a,b   Boggs, Angela A ^a,b   DiPaula, Bethany ^a,b   Siddiqi, Shahida ^a  

^a Springfield Hospital Center   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Adverse drug reactions; Drug interactions; Preventable adverse drug reactions; Psychiatry

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANXIOLYTIC AGENT; BENZOYL PEROXIDE; CARDIOVASCULAR AGENT; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; DESMOPRESSIN; FLUPHENAZINE; HALOPERIDOL; HYDROCHLOROTHIAZIDE; IBUPROFEN; LISINOPRIL; LITHIUM; LORAZEPAM; METOPROLOL; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; PEGINTERFERON ALPHA2A; PROPRANOLOL; QUETIAPINE; RISPERIDONE; UNINDEXED DRUG; VARICELLA ZOSTER VACCINE; WARFARIN; ZOLPIDEM;

ANEMIA; ANGIONEUROTIC EDEMA; ARTICLE; ATAXIA; BRADYCARDIA; CONFUSION; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; DIZZINESS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DYSLIPIDEMIA; DYSTONIA; FALLING; GAIT DISORDER; GASTROINTESTINAL HEMORRHAGE; HAND TREMOR; HOSPITALIZATION; HUMAN; HYPONATREMIA; HYPOTENSION; MEDICAL EDUCATION; MENTAL HEALTH; MENTAL HOSPITAL; MENTAL PATIENT; NEUROLEPTIC MALIGNANT SYNDROME; NEUTROPENIA; OCULOGYRIC CRISIS; ORTHOSTATIC HYPOTENSION; PATIENT CARE; PATIENT SAFETY; PETECHIA; PRIORITY JOURNAL; SEDATION; SEIZURE; SIDE EFFECT; SLURRED SPEECH; SOMNOLENCE; TOUNGE DYSTONIA; TREMOR; TRISMUS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; CARDIOVASCULAR AGENTS; DRUG INTERACTIONS; DRUG TOXICITY; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; MARYLAND; MENTAL DISORDERS; PROBABILITY; RETROSPECTIVE STUDIES;

EID: 77951560531     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M746     Document Type: Article

References (16)

1. The Joint Commission. Standard MM.07.01.03. In: 2010 Hospital Accreditation Standards. Illinois: Joint Commission Resources, Inc., 2010:MM-21-MM-22.
2. Ducharme MM, Boothby LA. Analysis of adverse drug reactions for preventability. Int J Clin Pract 2007;61:157-161
3. Kanjanarat P,Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health Syst Pharm 2003;60:1750-1759
4. Winterstein AG, Hatton RC, Gonzalez-Rothi R, Johns TE, Segal R. Identifying clinically significant preventable adverse drug events through a hospital's database of adverse drug reaction reports. Am J Health Syst Pharm 2002;59:1742-1749
5. Al-Tajir GK, Kelly WN. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother 2005; 39:1169-1174 DOI 10.1345/aph.1E559
6. Rothschild JM, Mann K, Keohane CA, et al. Medication safety in a psychiatric hospital. Gen Hosp Psychiatry 2007;29:156-162
7. Mann K, Rothschild JM, Keohane CA, Chu JA, Bates DW. Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification (abstract). World J Biol Psychiatry 2008;9:24.
8. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm 1995;52:417-419
9. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245 (Pubitemid 12149145)
10. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27:538.
11. Gurwitz JH, Field TS, Judge J, et al. The incidence of adverse drug events in two large academic long-term care facilities. Am J Med 2005;118:251-258
12. Juurlink DN, Mamdani MM, Kopp A, Rochan PA, Schulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc 2004;52:794-798
13. SAFE MD: Practical applications and approaches to safe psychiatric practice. Arlington, VA: American Psychiatric Association, 2008.
14. Popli AP, Hegarty JD, Siegel AL, Kando JC, Tohen M. Transfer of psychiatric inpatients to a general hospital due to adverse drug reactions. Psychosomatics 1997;38:35-37
15. National Patient Safety Goals. 2009 National Patient Safety Goals Hospital Program. The Joint Commission. www.jointcommission.org (accessed 2009 Oct 14).
16. Institute of Safe Medication Practices. High alert medications. www.ismp.org/Tools/highalertmedications.pdf (accessed 2009 Nov 16).